BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21884004)

  • 1. Imidazoline antihypertensive drugs: selective i(1) -imidazoline receptors activation.
    Nikolic K; Agbaba D
    Cardiovasc Ther; 2012 Aug; 30(4):209-16. PubMed ID: 21884004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of the imidazoline receptors in toxicology.
    Lowry JA; Brown JT
    Clin Toxicol (Phila); 2014 Jun; 52(5):454-69. PubMed ID: 24666288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. I1 receptors, cardiovascular function, and metabolism.
    Bousquet P
    Am J Hypertens; 2001 Nov; 14(11 Pt 2):317S-321S. PubMed ID: 11721890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of I1 imidazoline receptors: their role in blood pressure regulation.
    Bousquet P
    Am J Hypertens; 2000 Jun; 13(6 Pt 2):84S-88S. PubMed ID: 10921526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moxonidine: a new antiadrenergic antihypertensive agent.
    Prichard BN; Graham BR; Owens CW
    J Hypertens Suppl; 1999 Aug; 17(3):S41-54. PubMed ID: 10489098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renaissance of centrally acting antihypertensive drugs.
    van Zwieten PA
    J Hypertens Suppl; 1999 Aug; 17(3):S15-21. PubMed ID: 10489094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.
    Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO
    J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR study of imidazoline antihypertensive drugs.
    Nikolic K; Filipic S; Agbaba D
    Bioorg Med Chem; 2008 Aug; 16(15):7134-40. PubMed ID: 18621536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interruption of central neuronal pathway of imidazoline I1 receptor mediates the hypertensive effect of cyclosporine in rats.
    El-Mas MM; Omar AG; Helmy MM; Mohy El-Din MM
    Brain Res; 2009 Jan; 1248():96-106. PubMed ID: 19028461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN; Owens CW; Graham BR
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imidazoline Receptor System: The Past, the Present, and the Future.
    Bousquet P; Hudson A; García-Sevilla JA; Li JX
    Pharmacol Rev; 2020 Jan; 72(1):50-79. PubMed ID: 31819014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral involvement of imidazoline system.
    Nechifor M; Ciubotariu D
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):552-6. PubMed ID: 23077952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imidazoline receptors. A new concept in central regulation of the arterial blood pressure.
    Bousquet P; Feldman J; Tibirica E; Bricca G; Greney H; Dontenwill M; Stutzmann J; Belcourt A
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):47S-50S. PubMed ID: 1350728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Centrally acting antihypertensives: a renaissance of interest. Mechanisms and haemodynamics.
    van Zwieten PA
    J Hypertens Suppl; 1997 Jan; 15(1):S3-8. PubMed ID: 9050980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imidazoline receptors: from basic concepts to recent developments.
    Bousquet P
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S1-6. PubMed ID: 8642798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of medullary I1-imidazoline and alpha 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats.
    Buccafusco JJ; Lapp CA; Westbrooks KL; Ernsberger P
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1162-71. PubMed ID: 7791087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
    Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
    Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Centrally acting sympathetic inhibitors for therapy of patients with hypertension].
    Kawasaki H
    Nihon Rinsho; 1997 Aug; 55(8):2081-5. PubMed ID: 9284427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of NMDA and AMPA/kainate receptors involved in cardiovascular inhibition produced by imidazoline-like drugs in anaesthetized rats.
    Wang LG; Zeng J; Yuan WJ; Su DF; Wang WZ
    Exp Physiol; 2007 Sep; 92(5):849-58. PubMed ID: 17573415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of imidazolines and imidazoline receptors role at the vascular level.
    Serban DN; Nechifor M; Slătineanu SM
    Rev Med Chir Soc Med Nat Iasi; 2000; 104(4):37-44. PubMed ID: 12089957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.